Kevin Caliendo
Stock Analyst at UBS
(4.17)
# 494
Out of 5,005 analysts
186
Total ratings
67.39%
Success rate
8.93%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Initiates: Neutral | $77 | $74.00 | +4.05% | 1 | Oct 1, 2025 | |
| PINC Premier | Maintains: Neutral | $26 → $28 | $27.90 | +1.27% | 3 | Sep 25, 2025 | |
| MCK McKesson | Maintains: Buy | $820 → $860 | $738.06 | +16.52% | 15 | Sep 24, 2025 | |
| CVS CVS Health | Upgrades: Buy | $67 → $79 | $77.49 | +1.95% | 9 | Aug 18, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $13 → $7 | $4.76 | +47.06% | 6 | Aug 13, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $25 → $24 | $13.19 | +81.96% | 11 | Aug 8, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $8.5 → $9 | $5.51 | +63.34% | 5 | Aug 8, 2025 | |
| HSIC Henry Schein | Maintains: Neutral | $75 → $70 | $67.03 | +4.43% | 6 | Aug 6, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $18 → $22 | $20.85 | +5.52% | 4 | Jul 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $260 → $180 | $201.97 | -10.88% | 4 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $282 → $305 | $276.94 | +10.13% | 5 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $180 | $179.33 | +0.37% | 15 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $385 | $360.20 | +6.89% | 12 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $10 | $18.94 | -47.20% | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $5.25 | $4.53 | +15.89% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $8.23 | +82.26% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $6.33 | +42.18% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $17 | $16.62 | +2.29% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $170 | $154.46 | +10.06% | 17 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $302.76 | +10.65% | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $215 | $132.17 | +62.67% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $311.00 | +25.40% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $283.72 | -11.88% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $38.70 | +104.13% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $350.50 | +64.05% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $188.64 | -4.58% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $9.01 | +699.11% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $20.01 | -45.03% | 4 | May 4, 2021 |
Solventum
Oct 1, 2025
Initiates: Neutral
Price Target: $77
Current: $74.00
Upside: +4.05%
Premier
Sep 25, 2025
Maintains: Neutral
Price Target: $26 → $28
Current: $27.90
Upside: +1.27%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $738.06
Upside: +16.52%
CVS Health
Aug 18, 2025
Upgrades: Buy
Price Target: $67 → $79
Current: $77.49
Upside: +1.95%
Owens & Minor
Aug 13, 2025
Maintains: Buy
Price Target: $13 → $7
Current: $4.76
Upside: +47.06%
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $13.19
Upside: +81.96%
LifeStance Health Group
Aug 8, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $5.51
Upside: +63.34%
Henry Schein
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $67.03
Upside: +4.43%
Envista Holdings
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $20.85
Upside: +5.52%
Molina Healthcare
Jul 25, 2025
Maintains: Neutral
Price Target: $260 → $180
Current: $201.97
Upside: -10.88%
Jul 25, 2025
Maintains: Buy
Price Target: $282 → $305
Current: $276.94
Upside: +10.13%
Jul 23, 2025
Maintains: Neutral
Price Target: $175 → $180
Current: $179.33
Upside: +0.37%
Jun 25, 2025
Maintains: Buy
Price Target: $400 → $385
Current: $360.20
Upside: +6.89%
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $18.94
Upside: -47.20%
May 13, 2025
Maintains: Neutral
Price Target: $6 → $5.25
Current: $4.53
Upside: +15.89%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $8.23
Upside: +82.26%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.33
Upside: +42.18%
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $16.62
Upside: +2.29%
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $154.46
Upside: +10.06%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $302.76
Upside: +10.65%
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $132.17
Upside: +62.67%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $311.00
Upside: +25.40%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $283.72
Upside: -11.88%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $38.70
Upside: +104.13%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $350.50
Upside: +64.05%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $188.64
Upside: -4.58%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $9.01
Upside: +699.11%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $20.01
Upside: -45.03%